U.S. drugs giant Amgen buys out Mustafa Nevzat for $700 million.
U.S. drugs giant Amgen has announced that it has agreed to buy out Turkish Mustafa Nevzat for $700 million. Amgen
Read More
Amgen
Turkish generic producer to receive a big offer from pharma giants for minority stakes
Although the Turkish pharmaceutical sector has been going through a challenging period foreign enterprises have not ceased keeping a good
Read More